Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Alveolar echinococcosis (AE) is a rare parasitic disorder that occurs after ingestion of eggs of Echinococcus multilocularis. AE is characterized by an initial asymptomatic incubation period of many years followed by a chronic course where the clinical manifestations include epigastric pain and jaundice.
Features include very common findings: Hepatic cysts, Increased total eosinophil count, Elevated erythrocyte sedimentation rate, and Elevated antibody levels (increased circulating immunoglobulin concentration); and common findings: Jaundice, Decreased liver function, Low red blood cell count (anemia), and Fever and others. 50 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 9 |
Biomarker and diagnostic research for alveolar echinococcosis has been reported in the published literature.
Phenotype severity distribution: 4 very common features, 10 common features.
Estimated prevalence: Unknown (Unknown prevalence).
6 clinical trials registered, 5 recruiting. Interventions under study include procedural interventions, other interventions, and biologic therapy. Pipeline includes 1 EARLY_PHASE1, 2 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06612229](https://clinicaltrials.gov/study/NCT06612229) |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 4:48 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Brain and nerves | 6 | Fatigue, Headache, Seizure |
Bones and joints | 4 | Abnormal vertebral morphology, Abnormal skeletal muscle morphology, Bone cyst |
Heart and blood vessels | 3 | Chest pain, Portal hypertension, Abnormal membrane around the heart (abnormal pericardium morphology) |
Lungs and breathing | 2 | Dyspnea, Pulmonary cyst |
Lab test results | 1 | Elevated antibody levels (increased circulating immunoglobulin concentration) |
Blood and immune system | 1 | Low red blood cell count (anemia) |
Metabolism | 1 | Fever |
Kidneys and urinary system | 1 | Renal cyst |
Growth and development | 1 | Weight loss |
Hormones | 1 | Abnormal adrenal morphology |
Ears | 1 | Vertigo |
Muscles | 1 | Abnormal skeletal muscle morphology |
Biliary Fistulas in Surgery of Liver Echinococcosis |
NA |
Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov |
RECRUITING |
[NCT06316154](https://clinicaltrials.gov/study/NCT06316154) | Presentation of Protoscolexes and Acephalocysts in the Fibrous Capsule Area of the Liver With Echinococcosis | — | Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov | RECRUITING |
[NCT07333612](https://clinicaltrials.gov/study/NCT07333612) | IM Bands in Inactive Hepatic CE | — | Fondazione IRCCS Policlinico San Matteo di Pavia | RECRUITING |
[NCT05824442](https://clinicaltrials.gov/study/NCT05824442) | Evaluation of a New Multiplex Quantitative PCR Technique for the Diagnosis of Echinococcosis | NA | Centre Hospitalier Universitaire de Besancon | RECRUITING |
[NCT07551063](https://clinicaltrials.gov/study/NCT07551063) | 5G Remote Robotic Surgery for Hepatic Echinococcosis in High-Altitude Region | EARLY_PHASE1 | West China Hospital | NOT_YET_RECRUITING |
323 publications have been identified in PubMed for alveolar echinococcosis. Kisho has analyzed 257 by research type. Research spans Basic Science / Preclinical (24%), Case Report / Case Series (19%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 62 | 24% |
Patient case studies | 49 | 19% |
Disease patterns and progression | 47 | 18% |
Testing and diagnosis research | 35 | 14% |
Research summaries | 35 | 14% |
New treatment approaches | 15 | 6% |
Clinical study results | 9 | 4% |
Other research | 5 | 2% |
Wang Y (2026). [PMID: 41882584](https://pubmed.ncbi.nlm.nih.gov/41882584/). *BMC Infect Dis*. [Case Report / Case Series]
Esselmani H (2026). [PMID: 41670084](https://pubmed.ncbi.nlm.nih.gov/41670084/). *Rev Soc Bras Med Trop*. [Case Report / Case Series]
Mamuti A (2026). [PMID: 41731876](https://pubmed.ncbi.nlm.nih.gov/41731876/). *Int J Surg*. [Review / Meta-Analysis]
Li F (2026). [PMID: 41925347](https://pubmed.ncbi.nlm.nih.gov/41925347/). *Liver Transpl*. [Basic Science / Preclinical]
Wang M (2026). [PMID: 41579443](https://pubmed.ncbi.nlm.nih.gov/41579443/). *J Colloid Interface Sci*. [Clinical Trial Publication]
Xin L (2026). [PMID: 41668262](https://pubmed.ncbi.nlm.nih.gov/41668262/). *Parasites Hosts Dis*. [Case Report / Case Series]
Uemura T (2026). [PMID: 42156060](https://pubmed.ncbi.nlm.nih.gov/42156060/). *Brain Nerve*. [Review / Meta-Analysis]
Seyfettin A (2026). [PMID: 41972949](https://pubmed.ncbi.nlm.nih.gov/41972949/). *Diagn Interv Radiol*. [Diagnostic / Biomarker]
Tian W (2026). [PMID: 41672495](https://pubmed.ncbi.nlm.nih.gov/41672495/). *Magn Reson Med Sci*. [Gene Therapy / Novel Therapeutics]
Husmann L (2026). [PMID: 41051686](https://pubmed.ncbi.nlm.nih.gov/41051686/). *Ann Nucl Med*. [Diagnostic / Biomarker]
AI-curated news mentioning alveolar echinococcosis
Updated Sep 7, 2026
A recent pathological study highlights the distinct growth patterns between hepatic alveolar echinococcosis and hepatocellular carcinoma. This research could inform future diagnostic and treatment strategies for these conditions.
A recent study highlights the emergence of alveolar echinococcosis in Canada, signaling potential risks for the USA. This research underscores the need for increased awareness and monitoring of this parasitic disease.
A case report details the successful management of portal vein invasion and cavernous transformation due to hepatic echinococcosis using Transjugular Intrahepatic Portosystemic Shunt (TIPS). This study contributes to the understanding of treatment options for complications arising from echinococcosis.